|
|
|
Insider
Information: |
Abercrombie George B |
Relationship: |
|
City: |
Durham |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
347,320 |
|
Indirect Shares
|
131,194 |
|
|
Direct
Value |
$4,488,694 |
|
|
Indirect Value
|
$88,687 |
|
|
Total
Shares |
478,514 |
|
|
Total
Value |
$4,577,381 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-13.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alaunos Therapeutics |
TCRT |
Director |
2010-04-05 |
25,000 |
2010-04-05 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
29,611 |
2013-03-05 |
0 |
Premium* |
|
Innoviva Inc |
INVA |
Sr. VP & Chief Comm. O... |
2018-08-21 |
285,479 |
2014-06-19 |
0 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
|
2019-08-31 |
7,230 |
2019-08-31 |
131,194 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FRTX |
Fresh Tracks Therapeutics... |
|
|
2019-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,230 |
|
- |
|
FRTX |
Fresh Tracks Therapeutics... |
|
|
2019-08-31 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
131,194 |
|
- |
|
FRTX |
Fresh Tracks Therapeutics... |
|
|
2019-08-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,164 |
|
- |
|
TCRT |
Alaunos Therapeutics |
Director |
|
2010-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2013-03-05 |
4 |
B |
$1.23 |
$3,690 |
D/D |
3,000 |
3,000 |
2.73 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2013-11-12 |
4 |
B |
$6.19 |
$18,570 |
D/D |
3,000 |
6,000 |
2.81 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2014-03-31 |
4 |
OE |
$1.71 |
$6,840 |
D/D |
4,000 |
10,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-10 |
4 |
S |
$12.70 |
$88,900 |
D/D |
(7,000) |
3,000 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-24 |
4 |
OE |
$2.63 |
$17,534 |
D/D |
6,667 |
9,667 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-24 |
4 |
AS |
$13.90 |
$92,671 |
D/D |
(6,667) |
3,000 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-07-15 |
4 |
AS |
$15.69 |
$78,450 |
D/D |
(5,000) |
3,000 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-07-15 |
4 |
OE |
$2.63 |
$13,150 |
D/D |
5,000 |
8,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-09-10 |
4 |
OE |
$1.71 |
$202,710 |
D/D |
71,000 |
74,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-09-10 |
4 |
S |
$15.09 |
$1,116,660 |
D/D |
(74,000) |
0 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-09-15 |
4 |
OE |
$2.63 |
$13,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-09-15 |
4 |
AS |
$15.06 |
$75,300 |
D/D |
(5,000) |
0 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-11-15 |
4 |
OE |
$3.32 |
$16,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-11-15 |
4 |
AS |
$12.27 |
$61,350 |
D/D |
(5,000) |
0 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-02-15 |
4 |
AS |
$18.50 |
$92,500 |
D/D |
(5,000) |
0 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-02-15 |
4 |
OE |
$3.32 |
$16,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-04-18 |
4 |
AS |
$11.04 |
$55,200 |
D/D |
(5,000) |
0 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-04-18 |
4 |
OE |
$3.32 |
$16,600 |
D/D |
5,000 |
5,000 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
29,611 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
|
2016-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
92,587 |
175,554 |
0 |
- |
|
INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
|
2016-02-19 |
4 |
D |
$12.28 |
$66,017 |
D/D |
(5,376) |
170,178 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|